Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Data collection methods, timing, and measures

From: A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices

Aim 1: Data collection methods, timing, and measures
 Pre-site visit phone interviews—once at baseline Organizational structure, key stakeholders, practice champion
Approaches to delivery of adolescent preventive care services (such as immunizations)
 Formal site visit—once at baseline Baseline workflows; baseline patient data collection: eligible patient population, patient demographics, and other characteristics of the patient population; baseline immunization rates; baseline community partnership data: existing education programs and efforts and existing partnerships; use of ALERT IIS and EHR to capture and track immunizations
 Practice survey (PS)—once at baseline Practice and practice’s patient demographics, practice change, payer mix, revenue and payments, and HPV vaccine priority
 ALERT IIS—at baseline Patient demographics (age, race/ethnicity, vaccination status, insurance status, and other covariates)
Aim 2: Data collection methods, timing, and measures
 Quality Improvement Change Questionnaire (QICA)—every 12 months Engaged leadership
Organized, evidence-based care; quality improvement strategy; continuous and team-based healing relationships; care coordination
 Site visits—monthly, for 18 months Workflows; patient data collection: eligible patient population, patient demographics, and other characteristics of the patient population; quarterly immunization rates; quarterly community partnership data: existing education programs and efforts; existing partnerships
 Intervention data entries—monthly PDSA cycle worksheets, workflow mapping, field notes
 Practice survey (PS), administered as needed to reflect change Practice and practice’s patient demographics, practice change, payer mix, revenue and payments, HPV vaccine priority
 ALERT IIS—quarterly Patient demographics (age, race/ethnicity, vaccination status, insurance status, and other covariates)
Aim 3: Data collection methods, timing, and measures
 Pre- and post-community partner group interviews Acceptability of HPV vaccination
 Patient/parent surveys—every 6 months Child and parents’ knowledge about cancer risk reduction and the HPV vaccine series; where and how information about HPV and cancer risk reduction via vaccination was sought; demographic information